Depression is a serious illness that requires lots of work and medications, so a person can feel better.
Now, scientists claim that there's one subtype of that illness that doesn't respond well to popular antidepressants.
Let's find out more!
A new subtype
Scientists at Stanford Medicine identified a new type of depression called the cognitive biotype, affecting 27% of depressed patients.
Unlike traditional antidepressants, this biotype doesn't respond well to commonly prescribed medications that target serotonin.
Cognitive tests and brain imaging revealed that these patients struggle with planning, self-control, focus, and suppressing inappropriate behavior.
These people need help and proper treatment like anyone else, but the commonly used methods don't work for them.
How can we help these people?
The study suggests alternative treatments to alleviate symptoms and restore social and occupational abilities.
The findings highlight the importance of personalized depression care and the need for improved measurement tools.
Further research aims to explore targeted medications and therapies for the cognitive biotype, offering hope for more effective treatments.
